Patients For Affordable Drugs

Cystic fibrosis families know that the cost of medication can be the difference between life and death for patients with CF. No parent should have to live in fear that their child won't be able to access the prescription drugs they need to survive. Visit PatientsForAffordableDrugs.org and learn how advocates like Don are sharing their experiences with high drug costs to create policy change and lower drug prices.

Use your voice to help change policy! Share your story with P4AD: actionnetwork.org/forms/base-sto… ¡Usa tu voz para cambiar las políticas! Comparte tu historia con P4AD: actionnetwork.org/forms/base-sto…

Our mobile billboard is out and about in Washington D.C.! 🇺🇸 The Supreme Court’s decision to decline pharma’s arguments against Medicare Negotiation is a win for patients. If you see the truck, share your pictures with us!

Today’s decision is a big win for patients in the fight against the pharmaceutical industry’s greed! The Supreme Court declined petitions from AstraZeneca, Bristol Myers Squibb, Janssen, Novartis, Novo Nordisk, and Boehringer Ingelheim challenging the Medicare Drug Price Negotiation Program – letting lower court rulings stand that will let the program move forward and continue delivering relief to patients. It’s US vs. pharma, and today, patients won!

🥳 A win for patients! 🥳 This morning, the Supreme Court declined petitions from six major drugmakers challenging the Medicare Drug Price Negotiation Program, allowing the program to continue delivering lower drug prices for patients across the nation. Medicare negotiation was a huge win for patients and taxpayers and, as a result, people on Medicare now have access to innovative, life-saving treatments at lower costs. Learn more about Big Pharma's efforts to undermine Medicare negotiation and how P4AD is working to protect it at FightPharma.org

💸 Big Pharma profits while patients struggle to afford the prescription drugs they need. Learn how our growing community of patients and allies are fighting back at PatientsForAffordableDrugs.org.

Fundada por David Mitchell, un paciente que vive con cáncer incurable, Patients For Affordable Drugs trabaja para empoderar y movilizar a pacientes y aliados, exigir responsabilidad a quienes tienen poder y luchar por políticas que transformen el sistema y hagan que los medicamentos recetados sean accesibles para todas las personas en Estados Unidos. Conoce más sobre nuestro trabajo y la lucha por precios justos en los medicamentos en Es.PatientsForAffordableDrugs.org. Founded by a patient living with incurable cancer, David Mitchell, Patients For Affordable Drugs strives to empower and mobilize patients and allies, hold accountable those in power, and fight to shape and achieve system-changing policies that make prescription drugs affordable for all people in the United States. Learn more about our work and the fight for prescription drugs at accessible prices at PatientsForAffordableDrugs.org. 🎥: @tiemponews @elplanetaboston

We’ve reached a new milestone: 40,000 vetted patient stories now on our map 🇺🇸 While we are proud to be fighting alongside thousands of patients, this is a reminder of the urgency needed to address the crisis of high drug prices. 40,000 is not just a number. This represents real stories of patients from every state and every congressional district. If you or someone you know is struggling with the high cost of prescription drugs, share your story today. Join us in urging Congress to make sure that every American can get the medications they need at prices they can afford. actionnetwork.org/forms/base-sto…

👏 Patients are finally able to access the lifesaving medication they need at a price they can afford thanks to the 2022 prescription drug law's $35 cap on insulin!

Patient adovcate Amelia is right, no one needs to suffer alone. If you struggle with the high cost of prescription drugs, share your story with P4AD. You can join our community of over 40,000 who are ready to shape policies in favor of patients. Share your story today: actionnetwork.org/forms/base-sto…

P4AD has reached 40,000 vetted patient stories. From every state. And every Congressional district. This isn’t just a milestone – it’s the sobering reality caused by a system that’s failing patients across the country. Behind each of these stories is someone forced to make impossible choices just to afford the medications they or a loved one needs. When this many people are speaking out and demanding change, lawmakers can’t afford to ignore it.

No one should have to drain their savings and miss out on family time to afford their medications. Unfortunately, this was the reality that P4AD Patient Advocate, Bob Parant lived before Medicare negotiation. But now, thanks to the 2022 prescription drug law and Medicare's ability to negotiate prices for the most costly and widely used prescription drugs, his drug, Entresto's price has been slashed by 62%! To learn more about the relief that Medicare negotiation is delivering to patients visit: MedicareNegotiation.org

Regeneron has become the latest pharmaceutical company to enter a most-favored-nation (MFN) pricing agreement with the Trump administration. The announcement came alongside the FDA’s expedited approval of Otarmeni. A gene therapy to treat a rare form of genetic deafness, which affects approximately 50 Americans born each year.

Cystic fibrosis families know that the cost of medication can be the difference between life and death for patients with CF. No parent should have to live in fear that their child won't be able to access the prescription drugs they need to survive. Visit PatientsForAffordableDrugs.org and learn how advocates like Don are sharing their experiences with high drug costs to create policy change and lower drug prices.

Have you or someone in your family struggled to afford your prescription drugs? Join our community of patients like Maureen and start your advocacy journey by sharing your story today: actionnetwork.org/forms/base-sto…

The Patients For Affordable Drugs team, in collaboration with We Are Más and the Information Futures Lab at Brown University, held the first event of a new project designed to better understand the challenges Hispanic and Latino communities face around high prescription drug prices. Through this project, we hope to work alongside patients and others in their communities to shed light on how these costs impact their ability to live healthy lives.

🚨 Pharma is hiking the prices of rare disease drugs after Medicare protections were weakened in the 2025 Reconciliation Package. In the first week of January, pharmaceutical companies raised prices on 208 drugs used to treat rare diseases in the first week of January, with over 80% of those hikes exceeding inflation. These hikes come as Congress has weakened Medicare drug price negotiation for rare disease drugs through the ORPHAN Cures Act. For patients like Ginny, who lives with LEMS and relies on Firdapse, her medication would have been eligible for negotiation before the ORPHAN Cures. Now, it is not. Congress removed one of the only tools available to lower the cost of the very drugs she relies on. The ORPHAN Cures Act does not protect patients with rare diseases. It protects pharmaceutical profits. Learn more and take action at PatientsForAffordableDrugs.org.

In her Letter to the Editor published in @WashTimes, P4ADNOW patient advocate Sonia Vega describes the harsh reality thousands of Hispanic patients live every day because of the high cost of prescription drugs. This is unacceptable and we must continue to push for system-changing reforms that prioritize the one in three patients who are currently unable to afford their medications at the pharmacy counter. Read Sonia's full LTE: tinyurl.com/2rbep6h2

Use your voice to help change policy! Share your story with P4AD: actionnetwork.org/forms/base-sto… ¡Usa tu voz para cambiar las políticas! Comparte tu historia con P4AD: actionnetwork.org/forms/base-sto…

🗣️ P4AD patient advocates like Mary know the powerful impact of sharing their struggles with high drug costs with lawmakers firsthand. Have you been affected by high drug prices? Get involved with advocacy by sharing your story today: actionnetwork.org/forms/base-sto…